Imidafenacin clinical trials
How each study uses imidafenacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2001 (1)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Ono Pharmaceutical Co. Ltd (3) · R-Pharm (1) · LG Life Sciences (1)
Related medicines
As reviewed, each with the page that says it.
- One of Cholinergic Antagonists source
- One of Antimuscarinics source
Studies
Open first, then newest update. How each study uses imidafenacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.CompletedPhase 3R-PharmNCT03575702Written as Uritos®How we know
- Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in JapanCompletedPhase 2Ono Pharmaceutical Co. LtdNCT00212706Written as ONO-8025 (KRP-197)How we know
- Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in JapanCompletedPhase 3Ono Pharmaceutical Co. LtdNCT00212732Written as ONO-8025 (KRP-197)How we know
- Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive BladderCompletedPhase 3Ono Pharmaceutical Co. LtdNCT00512785Written as imidafenacin, KRP-197/ONO-8025How we know
- Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive BladderCompletedPhase 4LG Life SciencesNCT01578304Written as ImidafenacinHow we know
Given beside what is tested · 1 — imidafenacin is usual care or a partner of the new treatment
Codes
What other systems call imidafenacin · ClinicalTrials.gg INT004176
- MeSH (NLM) C120953imidafenacinOne source NLM
- UNII (FDA) XJR8Y07LJOIMIDAFENACINConfirmed FDA, NLM, Wikidata
- Wikidata Q6003989imidafenacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83789ImidafenacinOne source FDA
- DrugBank DB09262One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C120953 | imidafenacin | One source NLM |
| UNII (FDA) | XJR8Y07LJO | IMIDAFENACIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6003989 | imidafenacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83789 | Imidafenacin | One source FDA |
| DrugBank | DB09262 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.